Boston Medical Center published study results in the Journal of Alzheimer’s Disease found observations that low levels of amyloid -β and tau proteins, biomarkers of Alzheimer’s disease (AD), in eye fluid were significantly associated with low cognitive score. This effort by Boston medical Center represents the first of its kind to connect known AD protein biomarkers in the eye to mental status. As it turns out, proteins may be a potential source for an accessible, cost-effective test to predict future Alzheimer’s disease.
The Boston team used samples of eye fluid from 80 patients who were previously scheduled for eye surgery.
Lauren Wright, MD, First AuthorSource: Eurek Alert